Pure Global

Clinical Trial - Trial jRCT2061220089

Access comprehensive clinical trial information for jRCT2061220089 through Pure Global AI's free database. This phase not specified trial is sponsored by Insmed Godo Kaisha and is currently Recruiting. The study focuses on Pulmonary Arterial Hypertension.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2061220089
Recruiting
Trial Details
Japan Registry Clinical Trial โ€ข jRCT2061220089
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Untitled Trial
An Open Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long Term use of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension

Study Focus

Interventional

Sponsor & Location

Insmed Godo Kaisha

United States of America;Argentina;Australia;Mexico;Phillipines;Austria;Belgium;Brazil;Denmark;Germa

Timeline & Enrollment

N/A

N/A

N/A

ICD-10 Classifications

Primary pulmonary hypertension
Other secondary pulmonary hypertension
Pulmonary heart disease and diseases of pulmonary circulation
Stenosis of pulmonary artery
Pulmonary heart disease, unspecified

Data Source

Japan Registry Clinical Trial

jRCT2061220089

Non-Device Trial